SCHEMBL6707

SCHEMBL6707

CCOC(=O)Cc1ccc(-c2ccc(-c3onc(C)c3C[C@@H](O)SCc3ccccc3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 3/20 0.41
ALDH1A1 P00352 4/20 0.40
LPAR2 Q9HBW0 2/20 0.39
LPAR3 Q9UBY5 2/20 0.39
L3MBTL1 Q9Y468 6/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
ALOX15 P16050 1/20 0.36
CRHBP P24387 1/20 0.36
HTT P42858 1/20 0.36
CRHR2 Q13324 1/20 0.36
NPC1 O15118 1/20 0.36
PKM P14618 1/20 0.36
NFKB1 P19838 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
TSHR P16473 2/20 0.36
HSD17B10 Q99714 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7741 0.91 CYP4F2 (0.39) LPAR1ALDH1A1LPAR2LPAR3L3MBTL1
SCHEMBL7722 0.89 LPAR1 (0.48) LPAR1ALDH1A1LPAR2LPAR3L3MBTL1
SCHEMBL6871 0.87 EPHX1 (0.40) ALDH1A1HTTTHRB
SCHEMBL7577 0.83 FFAR1 (0.43) LPAR1LPAR2LPAR3
SCHEMBL1233 0.83 CYP2C9 (0.42) LPAR1ALDH1A1TSHRNPSR1KDM4E
SCHEMBL2337 0.83 CYP2C9 (0.42) LPAR1ALDH1A1TSHRNPSR1KDM4E
SCHEMBL18597759 0.83 LPAR1 (0.42) LPAR1ALDH1A1LPAR2LPAR3L3MBTL1
SCHEMBL6148 0.82 ALDH1A1 (0.42) LPAR1ALDH1A1LPAR2LPAR3L3MBTL1
SCHEMBL2265 0.79 LPAR1 (0.49) LPAR1ALDH1A1LPAR2LPAR3SMN1; SMN2
SCHEMBL1869 0.79 LPAR1 (0.49) LPAR1ALDH1A1LPAR2LPAR3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed